Issue Information.
- Published in:
- International Journal of Immunogenetics, 2024, v. 51, n. 6, p. i, doi. 10.1111/iji.12653
- Publication type:
- Article
Works matching IS 17443121 AND DT 2024 AND VI 51 AND IP 6
Results: 6
1
2
Role of C–C chemokine receptor type 5 in pathogenesis of malaria and its severe forms.
- Published in:
- International Journal of Immunogenetics, 2024, v. 51, n. 6, p. 369, doi. 10.1111/iji.12700
- By:
- Publication type:
- Article
3
Nomenclature for factors of the HLA system, update July, August and September 2024.
- Published in:
- International Journal of Immunogenetics, 2024, v. 51, n. 6, p. 397, doi. 10.1111/iji.12699
- By:
- Publication type:
- Article
4
Investigations of associations between TNF‐α promoter polymorphisms and genetic susceptibility to type 2 diabetes mellitus: A cross‐sectional study in Chinese Han population.
- Published in:
- International Journal of Immunogenetics, 2024, v. 51, n. 6, p. 388, doi. 10.1111/iji.12698
- By:
- Publication type:
- Article
5
Correction to Abstracts from the 34th BSHI Annual Conference (2024), 24 September 2024, Manchester.
- Published in:
- International Journal of Immunogenetics, 2024, v. 51, n. 6, p. 433, doi. 10.1111/iji.12697
- Publication type:
- Article
6
Does HLA‐DQA1*05 carriage have a greater impact on the outcome of infliximab therapy for isolated small‐bowel Crohn's disease?
- Published in:
- International Journal of Immunogenetics, 2024, v. 51, n. 6, p. 380, doi. 10.1111/iji.12696
- By:
- Publication type:
- Article